You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Colorcon
Boehringer Ingelheim
Baxter
McKesson

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Patent: 5,981,260

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,981,260
Title: Process for the production of cell mass and/or fermentation products under sterile conditions
Abstract:Process for the production of cell mass and/or fermentation products under sterile conditions, during which the fermentation mixture, at least at times, is recycled and the metabolic products of the cultivated cells, and possibly the cell mass are separated; the process comprises the following steps: charging the fermentation equipment with a sufficient amount of nutrient medium to start the required cell culture. sterilizing the equipment as well as adjustment of the required concentration of nutrient medium, inoculation of the nutrient medium with the starter culture and allowing undisturbed growth of the culture for a defined time, increasing the concentration of the nutrient medium to the specific nutrient medium concentration of the cell culture by simultaneously increasing the volume of the nutrient medium to the working volume of the fermenter and increasing the concentration of cells, transition to continuous procedure with exchange of the nutrient medium and separation of the metabolic products as well as complete or partial cell recycling, termination of the continuous procedure at a required time, harvest of the cell mass under sterile conditions, and possibly repetition of some or all of the abovementioned steps in the order stated, as well as a device for the implementation of these processes.
Inventor(s): Metz; Michael (D-7000 Stuttgart 1, DE)
Assignee:
Application Number:07/795,899
Patent Claims:see list of patent claims

Details for Patent 5,981,260

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial 2016-11-09 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial 2016-11-09 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Colorcon
Medtronic
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.